Perceived Effectiveness of the Vaginal Moisturizer Investigational Product Under Normal Conditions of Use.
NCT ID: NCT06353945
Last Updated: 2024-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2024-06-10
2024-07-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product
NCT05300984
Efficacy of Four Topical Products to Improve Skin Longevity
NCT07118943
POST-MARKETING CLINICAL STUDY to EVALUATE the EFFICACY and SAFETY of the VAGINAL FILLER MEDICAL DEVICE in CORRECTING THINNING of the GENITAL TISSUE of the LABIA MAJORA in WOMEN, RE-PROPORTIONING the FEMALE EXTERNAL GENITAL AREA and IMPROVING SEXUAL FUNCTION.
NCT06797167
CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women
NCT05336825
Proof of Concept Anti-ageing Clinical Study in Healthy Subjects
NCT03180645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vaginal moisturizer
45 participants treated with vaginal moisturizer
vaginal moisturizer
vaginal moisturizer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vaginal moisturizer
vaginal moisturizer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Phototypes: I to IV, according to Fitzpatrick classification;
3. Sex: female
4. Intact skin in the evaluation region.
5. Participants complaining of vaginal dryness;
6. Agree to adhere to the study procedures and requirements: study time, return(s) to the laboratory to perform study procedures, home use of the investigational product, filling out the usage diary, not changing cosmetic habits during the study period .
7. Agree not to carry out dermatological or aesthetic treatments until the end of the study and agree not to use any products from the same category as the investigational product.
8. Signing of the Free and Informed Consent Form (TCLE).
Exclusion Criteria
2. Skin marks in the experimental area that interfere with the assessment of possible skin reactions.
3. Active dermatoses (local or disseminated) that could interfere with the study results.
4. History of ineffectiveness, allergic reactions, irritation or intense sensation of discomfort to topical products: health products or medications.
5. Expected vaccination during the study or up to 3 weeks before the study;
6. Not taking vitamin A (acid and/or its derivatives orally or topically up to 1 month before the start of the study.)
7. Patients with immunodeficiencies.
8. History of atopy (atopic dermatitis, allergic rhinitis, allergic bronchitis, allergic conjunctivitis, etc.).
9. Use of non-steroidal anti-inflammatory drugs, corticosteroids, antihistamines, photosensitizers or immunosuppressants up to 2 weeks before the study (or considering depot corticosteroids, the interval should be 1 month before the selection).
10. Aesthetic or dermatological treatment up to 4 weeks before the study.
11. Hormonal treatments not stable in the last 3 months.
12. Hyperpigmentation associated with the use of drugs such as tetracyclines, phenothiazides or amiodarone.
13. Hyperpigmentation associated with photosensitivity.
14. People directly involved in carrying out this study and their families.
15. History of lack of adherence or unwillingness to adhere to the study protocol.
16. Any condition that, in the researcher's opinion, could compromise the study.
17. Be participating in another study in the same region of application.
25 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herbarium Laboratorio Botanico Ltda
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kosmoscience Ciência e Tecnologia Cosmética Ltda
Campinas, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HB062-24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.